Middle EAST Primary Biliary Cholangitis Therapeutics Market...

добавлена новая статья Aura & Çakra

2026-03-09 10:51:01 -

Middle EAST Primary Biliary Cholangitis Therapeutics Market Analysis Report: Growth Factors, Challenges, and Opportunities

The Middle EAST Primary Biliary Cholangitis Therapeutics Market was valued at USD 0.25 billion in 2024 and is projected to reach USD 0.55 billion by 2034, registering a CAGR of 8.5%. This growth trajectory is underpinned by several factors, including the rising prevalence of primary biliary cholangitis (PBC), increasing awareness of the disease, and advancements in therapeutic options. The...

0 Комментарии 0 Поделились 299 Просмотры 0 предпросмотр